Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Beta-catenin
100%
Cholestasis
100%
Bile Acid Metabolism
100%
Farnesoid X Receptor
100%
Cholestatic Liver Disease
45%
Bile Acids
27%
Knock-in Mouse Model
18%
Fibrosis
18%
Receptor Activation
18%
Ductular Proliferation
18%
Nuclear Translocation
9%
Inflammation
9%
Receptor Complex
9%
Therapeutic Potential
9%
Hepatic Injury
9%
Liver Injury
9%
Liver-specific
9%
Sequester
9%
Littermate
9%
Nuclear Localization
9%
Short-term Exposure
9%
Retinoid X Receptor
9%
Bile Flow
9%
Hepatology
9%
Promoter Activation
9%
Total Bile Acid
9%
Complex Activation
9%
Physical Complexity
9%
Bile Duct Ligation
9%
Bile Acid Transport
9%
Nuclear Corepressor
9%
3,5-diethoxycarbonyl-1,4-dihydrocollidine
9%
Promoter Occupancy
9%
Bile Duct Development
9%
Pharmacology, Toxicology and Pharmaceutical Science
Catenin
100%
Murine
100%
Cholestasis
100%
Bile Acid
100%
Farnesoid X Receptor
100%
Liver Injury
18%
Liver Disease
18%
Fibrosis
18%
Knockout Mouse
18%
Inflammation
9%
Receptor Agonist
9%
Heterodimer
9%
1,4 Dihydro 2,4,6 Trimethyl 3,5 Pyridinedicarboxylic Acid Diethyl Ester
9%
Retinoid X Receptor
9%
Biochemistry, Genetics and Molecular Biology
Catenin
100%
Murine
100%
Bile Acid Metabolism
100%
Farnesoid X Receptor
100%
Bile Acid
36%
Knockout Mouse
18%
Wild Type
9%
Receptor Agonists
9%
Bile Acid Synthesis
9%
Retinoid X Receptor
9%
Bile Flow
9%
Corepressor
9%
Promoter Protein
9%
Medicine and Dentistry
Bile Acid Metabolism
100%
Farnesoid X Receptor
100%
1,4 Dihydro 2,4,6 Trimethyl 3,5 Pyridinedicarboxylic Acid Diethyl Ester
9%